About Hervolution
Hervolution is a company based in Copenhagen (Denmark) founded in 2018.. Hervolution has raised $18.17 million across 2 funding rounds from investors including Serum Institute of India, European Union and EIC Fund. The company has 13 employees as of November 30, 2024. Hervolution offers products and services including Immunotherapy Platform and Pipeline Assets. Hervolution operates in a competitive market with competitors including Ardelyx, VBI Vaccines, HilleVax, DermBiont and Inozyme Pharma, among others.
- Headquarter Copenhagen, Denmark
- Employees 13 as on 30 Nov, 2024
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Inprother Aps
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$18.17 M (USD)
in 2 rounds
-
Latest Funding Round
$11.7 M (USD), Series A
Dec 19, 2024
-
Investors
Serum Institute of India
& 2 more
-
Employee Count
13
as on Nov 30, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Hervolution
Hervolution offers a comprehensive portfolio of products and services, including Immunotherapy Platform and Pipeline Assets. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Engineers therapies targeting HERVs for disease treatment.
Off-the-shelf assets for cancer and metabolic disease interventions.
Funding Insights of Hervolution
Hervolution has successfully raised a total of $18.17M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $11.7 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $11.7M
-
First Round
First Round
(24 May 2023)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2024 | Amount | Series A - Hervolution | Valuation | Serum Institute of India | |
| May, 2023 | Amount | Seed - Hervolution | Valuation | EIC Fund |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Hervolution
Hervolution has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Serum Institute of India, European Union and EIC Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
Vaccines and immuno-biological drugs for infectious diseases are manufactured.
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Hervolution
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Hervolution
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Hervolution Comparisons
Competitors of Hervolution
Hervolution operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ardelyx, VBI Vaccines, HilleVax, DermBiont and Inozyme Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal, cardio-renal, and metabolic diseases are developed.
|
|
| domain | founded_year | HQ Location |
VBI Vaccines is engaged in developing vaccines and immunotherapeutics.
|
|
| domain | founded_year | HQ Location |
A norovirus vaccine is developed for infection prevention.
|
|
| domain | founded_year | HQ Location |
Microbial therapeutics for skin diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of treatments for rare and debilitating metabolic diseases
|
|
| domain | founded_year | HQ Location |
Vaccines for infectious diseases, including antigens and adjuvants, were developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Hervolution
Frequently Asked Questions about Hervolution
When was Hervolution founded?
Hervolution was founded in 2018 and raised its 1st funding round 5 years after it was founded.
Where is Hervolution located?
Hervolution is headquartered in Copenhagen, Denmark.
Is Hervolution a funded company?
Hervolution is a funded company, having raised a total of $18.17M across 2 funding rounds to date. The company's 1st funding round was a Seed of $6.47M, raised on May 24, 2023.
How many employees does Hervolution have?
As of Nov 30, 2024, the latest employee count at Hervolution is 13.
What does Hervolution do?
Hervolution was founded in 2018 and is headquartered in Copenhagen, Denmark. Focus is placed on the biotechnology sector, where immunotherapies for cancer treatment are developed. A lead candidate, IPT001, is advanced as a vaccine that employs Adenoviral and RNA vectors. Human Endogenous Retroviruses are targeted as antigens specific to tumors and senescence. Operations involve research into oncology solutions through endogenous viral elements.
Who are the top competitors of Hervolution?
Hervolution's top competitors include Ardelyx, HilleVax and VBI Vaccines.
What products or services does Hervolution offer?
Hervolution offers Immunotherapy Platform and Pipeline Assets.
Who are Hervolution's investors?
Hervolution has 3 investors. Key investors include Serum Institute of India, European Union, and EIC Fund.